PL3351620T3 - Hodowla komórek zoptymalizowana metabolicznie - Google Patents

Hodowla komórek zoptymalizowana metabolicznie

Info

Publication number
PL3351620T3
PL3351620T3 PL18161278T PL18161278T PL3351620T3 PL 3351620 T3 PL3351620 T3 PL 3351620T3 PL 18161278 T PL18161278 T PL 18161278T PL 18161278 T PL18161278 T PL 18161278T PL 3351620 T3 PL3351620 T3 PL 3351620T3
Authority
PL
Poland
Prior art keywords
cell culture
optimized cell
metabolically optimized
metabolically
culture
Prior art date
Application number
PL18161278T
Other languages
English (en)
Polish (pl)
Inventor
Shawn Lawrence
Ann KIM
Amy Johnson
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52813657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3351620(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of PL3351620T3 publication Critical patent/PL3351620T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/60Buffer, e.g. pH regulation, osmotic pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
PL18161278T 2013-10-11 2014-10-10 Hodowla komórek zoptymalizowana metabolicznie PL3351620T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361889815P 2013-10-11 2013-10-11
EP18161278.9A EP3351620B1 (en) 2013-10-11 2014-10-10 Metabolically optimized cell culture
EP14851841.8A EP3055409B1 (en) 2013-10-11 2014-10-10 Metabolically optimized cell culture
PCT/US2014/059993 WO2015054554A1 (en) 2013-10-11 2014-10-10 Metabolically optimized cell culture

Publications (1)

Publication Number Publication Date
PL3351620T3 true PL3351620T3 (pl) 2021-03-08

Family

ID=52813657

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14851841T PL3055409T3 (pl) 2013-10-11 2014-10-10 Metabolicznie zoptymalizowana hodowla komórkowa
PL18161278T PL3351620T3 (pl) 2013-10-11 2014-10-10 Hodowla komórek zoptymalizowana metabolicznie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL14851841T PL3055409T3 (pl) 2013-10-11 2014-10-10 Metabolicznie zoptymalizowana hodowla komórkowa

Country Status (17)

Country Link
US (2) US20160244725A1 (cg-RX-API-DMAC7.html)
EP (3) EP3055409B1 (cg-RX-API-DMAC7.html)
JP (3) JP6663854B2 (cg-RX-API-DMAC7.html)
KR (4) KR102243980B1 (cg-RX-API-DMAC7.html)
CN (2) CN114717196A (cg-RX-API-DMAC7.html)
AU (2) AU2014331776B2 (cg-RX-API-DMAC7.html)
CA (1) CA2926049C (cg-RX-API-DMAC7.html)
DK (2) DK3351620T3 (cg-RX-API-DMAC7.html)
EA (2) EA033783B1 (cg-RX-API-DMAC7.html)
ES (2) ES2678945T3 (cg-RX-API-DMAC7.html)
HU (2) HUE051049T2 (cg-RX-API-DMAC7.html)
IL (2) IL244511A0 (cg-RX-API-DMAC7.html)
MX (2) MX376623B (cg-RX-API-DMAC7.html)
PL (2) PL3055409T3 (cg-RX-API-DMAC7.html)
SG (2) SG11201601681QA (cg-RX-API-DMAC7.html)
WO (1) WO2015054554A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201601550B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014331776B2 (en) 2013-10-11 2020-10-22 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US20160244726A1 (en) * 2013-10-11 2016-08-25 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
JP7260018B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260020B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260011B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260012B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7272480B2 (ja) * 2017-04-27 2023-05-12 株式会社三洋物産 遊技機
JP7310952B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7310945B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7310947B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7260013B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7260021B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7260009B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
WO2019071076A1 (en) 2017-10-06 2019-04-11 Lonza Ltd. AUTOMATED CONTROL OF CELL CULTURE BY SPECTROSCOPY RAMAN
CA3075679A1 (en) 2017-10-16 2019-04-25 Regeneron Pharmaceuticals, Inc. Perfusion bioreactor and related methods of use
EP3717656B1 (en) * 2017-11-30 2024-03-13 F. Hoffmann-La Roche AG Process for culturing mammalian cells
AR115318A1 (es) * 2018-03-29 2020-12-23 Genentech Inc Modulación de la actividad lactogénica en células de mamífero
GB201810772D0 (en) 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
JP7231355B2 (ja) * 2018-08-22 2023-03-01 日機装株式会社 細胞培養方法および細胞培養装置
JP2021535739A (ja) 2018-08-27 2021-12-23 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 下流精製でのラマン分光法の使用
JP2020151560A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
JP2020151559A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
EP3985097A1 (en) * 2020-10-14 2022-04-20 Sartorius Stedim Biotech GmbH A method and system for configuring and/or setup of a downstream process for processing a biomass

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
KR970029803A (ko) 1995-11-03 1997-06-26 김광호 반도체 메모리장치의 프리차지 회로
US6165741A (en) 1997-05-30 2000-12-26 The Trustees Of The University Of Pennsylvania Method for rapid detection of bacterial growth in cultures
US5972650A (en) 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
CA2434802C (en) 2001-01-16 2013-05-28 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
CA2417689C (en) 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Improved methods for growing mammalian cells in vitro
US7039770B1 (en) 2002-03-05 2006-05-02 Juniper Networks, Inc. Low latency request dispatcher
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
DK1623019T4 (en) 2003-05-15 2017-03-27 Wyeth Llc LIMITED GLUCOSE SUPPLY TO ANIMAL CELL CULTURE
US7531327B2 (en) * 2004-07-23 2009-05-12 Immunomedics, Inc. Methods and compositions for increasing longevity and protein yield from a cell culture
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
TWI364458B (en) * 2004-08-27 2012-05-21 Wyeth Res Ireland Ltd Production of tnfr-lg
EP1943333A2 (en) * 2005-11-02 2008-07-16 Wyeth a Corporation of the State of Delaware Methods for adapting mammalian cells
EP1973576B1 (en) 2005-11-28 2019-05-15 Genmab A/S Recombinant monovalent antibodies and methods for production thereof
US7575890B2 (en) 2006-01-18 2009-08-18 Oxygen Enterprises, Ltd. Method for rapid detection and evaluation of cultured cell growth
MX2009004519A (es) 2006-11-03 2009-05-12 Wyeth Corp Sustancias que inhiben la glucolisis en un cultivo de celulas.
EP2150617B1 (en) 2007-06-04 2014-10-22 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
ES2657055T3 (es) 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
MX2010013728A (es) * 2008-06-13 2011-01-14 Centocor Ortho Biotech Inc Metodos para lograr una alta densidad de celulas viables en cultivos de celulas de mamiferos.
US8470552B2 (en) * 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
EP2563904B1 (en) * 2010-04-26 2015-01-21 Novartis AG Improved cell culture medium
HUE030820T2 (en) * 2010-05-28 2017-06-28 Hoffmann La Roche Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
WO2014109858A1 (en) * 2013-01-14 2014-07-17 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
AU2014331776B2 (en) 2013-10-11 2020-10-22 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture

Also Published As

Publication number Publication date
US20160244725A1 (en) 2016-08-25
MX2016004564A (es) 2016-07-12
KR102610425B1 (ko) 2023-12-06
IL244511A0 (en) 2016-04-21
CN105637085A (zh) 2016-06-01
ES2833471T3 (es) 2021-06-15
EA033783B1 (ru) 2019-11-25
MX2020011334A (es) 2021-07-30
ES2678945T3 (es) 2018-08-21
MX384960B (es) 2025-03-14
EA201991976A1 (ru) 2020-04-02
HK1223122A1 (en) 2017-07-21
EP3351620A1 (en) 2018-07-25
HUE039551T2 (hu) 2019-01-28
KR102358807B1 (ko) 2022-02-08
ZA201601550B (en) 2023-05-31
DK3351620T3 (da) 2020-10-26
SG11201601681QA (en) 2016-04-28
KR20230038324A (ko) 2023-03-17
HUE051049T2 (hu) 2021-01-28
EP3055409A1 (en) 2016-08-17
CA2926049C (en) 2023-09-05
AU2014331776A1 (en) 2016-03-24
HK1253275A1 (en) 2019-06-14
KR20220020415A (ko) 2022-02-18
IL262833A (en) 2018-12-31
JP6663854B2 (ja) 2020-03-13
US20210087535A1 (en) 2021-03-25
MX376623B (es) 2025-03-07
JP2016532457A (ja) 2016-10-20
PL3055409T3 (pl) 2018-10-31
CN114717196A (zh) 2022-07-08
CA2926049A1 (en) 2015-04-16
EA201690600A1 (ru) 2016-09-30
EP3055409B1 (en) 2018-04-25
KR20160062032A (ko) 2016-06-01
AU2021200193B2 (en) 2023-08-24
KR102243980B1 (ko) 2021-04-26
WO2015054554A1 (en) 2015-04-16
JP2022009453A (ja) 2022-01-14
DK3055409T3 (en) 2018-07-30
AU2014331776B2 (en) 2020-10-22
SG10201800772TA (en) 2018-03-28
AU2021200193A1 (en) 2021-03-18
JP7377243B2 (ja) 2023-11-09
EP3055409A4 (en) 2016-09-28
JP2020072760A (ja) 2020-05-14
EP3351620B1 (en) 2020-09-02
EP3812453A1 (en) 2021-04-28
KR102510238B1 (ko) 2023-03-16
KR20210046835A (ko) 2021-04-28
JP6967620B2 (ja) 2021-11-17

Similar Documents

Publication Publication Date Title
IL262833A (en) Metabolically enriched cell culture
IL245572B (en) cell
EP2971014A4 (en) CELL CULTURE METHODS
EP2971040A4 (en) CELL CULTURE METHODS
SG10201700670WA (en) Cell culture
SG11201509558VA (en) Back-contact-type solar cell
EP2961825A4 (en) STRUCTURE FOR CULTIVATION OF CELLS
IL245392B (en) A method for cell culture
GB201420277D0 (en) Cell culture system
GB201318262D0 (en) Sram Cells
PL2970845T3 (pl) Bioreaktor
GB201310031D0 (en) Cell
GB201312332D0 (en) Cell locations
GB201306326D0 (en) Fuel cells
PL2978839T3 (pl) Sposób hodowli komórek
GB201307880D0 (en) Fuel cells
GB201211873D0 (en) Cell culture
SG11201507338PA (en) Method for culturing cells
GB201317614D0 (en) Fuel cell
GB201518180D0 (en) Fuel cell
GB201308905D0 (en) Cell culture
GB201306488D0 (en) Cell culture
GB201317589D0 (en) Cell
GB201320573D0 (en) T Cell
GB201303132D0 (en) Cell Line